Shane Bohnen Power - 17 Aug 2026 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Reporting relationship
SVP - General Counsel
Issuer ticker
TECH
Reported as of
17 Aug 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Aug 2026, 16:49:03 UTC
Prior SEC filing
18 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick as Attorney-in-Fact for Shane Bohnen pursuant to Power of Attorney previously filed.

Key filing fact

Shane Bohnen Power filed Form 4 for BIO-TECHNE Corp (TECH) on 19 Aug 2026.

Key facts

  • This page summarizes Shane Bohnen Power's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 2 reported transactions and 14 derivative rows are listed below.
  • Accepted by SEC: 19 Aug 2026, 16:49.

Change

  • Previous filing in this sequence was filed on 18 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001969581 Primary reporting owner

Bohnen Shane

Relationship
SVP - General Counsel
Address
614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature
/s/ Andrew Nick as Attorney-in-Fact for Shane Bohnen pursuant to Power of Attorney previously filed.
Signature date
19 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,360
Date
17 Aug 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+11,344
Change %
Price
$0.000000*
Shares after
11,344
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,344
Exercise price
Footnotes
F6, F11
TECH transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+18,432
Change %
Price
$0.000000*
Shares after
18,432
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
18,432
Exercise price
Footnotes
F6, F12
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,944
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,944
Exercise price
$66.97
Footnotes
F1
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,460
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,460
Exercise price
$120.46
Footnotes
F1
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,508
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,508
Exercise price
$94.52
Footnotes
F1
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,928
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,928
Exercise price
$73.76
Footnotes
F2
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
807
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
807
Exercise price
$84.61
Footnotes
F1
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
16,302
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16,302
Exercise price
$84.61
Footnotes
F3
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
13,488
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,488
Exercise price
$74.91
Footnotes
F4
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
17,897
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,897
Exercise price
$53.60
Footnotes
F5
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
13,992
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,992
Exercise price
Footnotes
F6, F7
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,012
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,012
Exercise price
Footnotes
F6, F8
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,669
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,669
Exercise price
Footnotes
F6, F9
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,664
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,664
Exercise price
Footnotes
F6, F10
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

Fully exercisable.

Footnote F2

Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027.

Footnote F3

Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.

Footnote F4

Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

Footnote F5

Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028.

Footnote F6

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F7

Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F8

Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F9

1,669 restricted stock units vest on 8/15/2027.

Footnote F10

2,332 restricted stock units vest on each of 8/15/2027 and 8/15/2028.

Footnote F11

3,781 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 3,782 restricted stock units vest on 8/17/2029.

Footnote F12

18,432 restricted stock units vest on 8/17/2029.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .